CRISPR/Cas9 technology targeting exon 2 generated a frame-shift mutation. Immunoblotting confirmed that both expression of the alpha and beta isoforms was absent in skeletal muscle and liver. (J:333249)
查看原文 参与反馈
CRISPR/Cas9 technology targeting exon 2 generated a frame-shift mutation. Immunoblotting confirmed that both expression of the alpha and beta isoforms was absent in skeletal muscle and liver. (J:333249)